logo
15:45 Mar 06

Brooks Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
61.00
-0.73 (-1.18%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Brooks Laboratories Ltd. Financials

Brooks Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
61.00
-0.73 (-1.18%)
15:45 Mar 06
Quality
image/svg+xml

41/100
Medium Financial Strength

Valuation
image/svg+xml

52/100
Affordable Valuation

Technical

21/100
Technically Bearish

Strength

7

Weakness

8

Opportunity

1

Threats

0

-10.15 %

ROE %

-8.05 %

ROA %

7.33

EPS

33.30

BVPS

-12.07 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
91.08 63.2 79.49 82.56 88.85
Operating Expenses +
105.43 89.62 76.28 77.62 80.93
Raw Material
64.89 46.42 55.22 54.22 55.42
Increase Decrease in Cost
-2.1 4.18 1.4 -0.15 -1
Other Manufacturing Expense
9.51 7.13 4.44 0 0
Employee Cost
19.15 17.34 10.54 12.96 14.7
Miscellaneous Expenses
17.9 24.29 25.68 24.95 11.81
Operating Profit
-14.35 -26.42 3.21 4.94 7.92
Other Income
0.91 0.2 0.96 0.88 1.35
Depreciation
7.35 7.03 1.77 1.6 1.56
Interest
3.1 2.18 0.84 1.03 1
Profit before tax and exceptio..
-23.9 -35.42 1.55 3.19 6.71
Exceptional Items
0 0.36 0 0 0
PBT
-23.9 -35.07 1.55 3.19 6.71
Provision for Taxation
-4.59 -7.32 0.03 0.18 0.18
Net Profit
-19.31 -27.74 1.53 3.02 6.53
NET Profit after MI
-16.19 -20.9 -19.59 -9.97 21.6
EPS
-7.82 -12.57 -7.65 -3.72 7.29
Operating Profit Margin (%)
-15.76 -41.8 4.04 5.98 8.91
Net Profit Margin (%)
-17.78 -33.07 -24.64 -12.08 24.31

Brooks Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 52.60 52.60 52.60 52.60 59.10 63.60
FII 0.10 0.00 0.00 0.00 0.00 0.00
Public 10.40 10.40 10.40 10.40 3.90 3.90
Others 36.90 37.00 37.00 37.00 37.00 32.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: